2005Qilu yixue zazhiRequires access

EFFECTS OF DIMETHYL SULFOXIDE AND SECOND-MESSENGER EFFECTOR ON CRYOPRESERVED PLATELET MEMBRANE EXPRESSIONS CD42b AND CD62p

Bo Sun

Open publisher page 0 citations

Abstract

Objective To observe the effect of cryopreservation with 0.02 dimethyl sulfoxide(DMSO) plus ThromboSol, a mixture of second-messenger effectors, on platelet membrane CD42b and CD62p, and to investigate the long-term (6 months) preservation effect of the platelet storage solution. Methods Platelet concentrates were treated with 0.02 DMSO, 0.06 DMSO and 0.02 DMSO plus ThromboSol, and then placed in liquid nitrogen. The samples were thawed and expression levels of CD42b and CD62p on platelet membrane were analyzed after one month, three months and six months, respectively. Results The platelet expression level of CD42b in the 0.02 DMSO-plus-ThromboSol group was not significantly different from those in the 0.06 DMSO group (F=3.13-5.01,q=1.12-1.76, P0.05), and the levels of both groups were higher than those in the 0.02 DMSO group (q=3.17-4.06, P0.05) one, three and six months later. The CD42b levels of the three groups were lower than those of the fresh platelets (q=3.09-4.15, P0.05). The platelets treated with 0.02 DMSO plus ThromboSol showed statistically lower CD62p expression than those frozen with 0.06 DMSO and 0.02 DMSO(F=5.75-9.77,q=3.20-4.34,P0.05). There were no obvious differences in CD62p expression between platelets treated with 0.06 DMSO and 0.02 DMSO (q=1.55-2.02, P0.05). But the three groups of frozen platelets showed significant increase of surface expression of CD62p in comparison to the fresh platelets (F=3.95, q=4.85-7.35, P0.01). Conclusion The second-messenger effectors could reduce the DMSO concentration. The 0.02 DMSO plus ThromboSol is superior to 0.06 DMSO in inhibiting the activation of platelets, and is stable within six months.

About this research paper

What this paper is about

Objective To observe the effect of cryopreservation with 0.02 dimethyl sulfoxide(DMSO) plus ThromboSol, a mixture of second-messenger effectors, on platelet membrane CD42b and CD62p, and to investigate the long-term (6 months) preservation effect of the platelet storage solution. Methods Platelet concentrates were treated with 0.02 DMSO, 0.06 DMSO and 0.02 DMSO plus ThromboSol, and then placed in liquid nitrogen. The samples were thawed and expression levels of CD42b and CD62p on platelet membrane were analyzed after one month, three months and six months, respectively. Results The platelet expression level of CD42b in the 0.02 DMSO-plus-ThromboSol group was not significantly different from those in the 0.06 DMSO group (F=3.13-5.01,q=1.12-1.76, P0.05), and the levels of both groups were higher than those in the 0.02 DMSO group (q=3.17-4.06, P0.05) one, three and six months later. The CD42b levels of the three groups were lower than those of the fresh platelets (q=3.09-4.15, P0.05). The platelets treated with 0.02 DMSO plus ThromboSol showed statistically lower CD62p expression than those frozen with 0.06 DMSO and 0.02 DMSO(F=5.75-9.77,q=3.20-4.34,P0.05). There were no obvious differences in CD62p expression between platelets treated with 0.06 DMSO and 0.02 DMSO (q=1.55-2.02, P0.05). But the three groups of frozen platelets showed significant increase of surface expression of CD62p in comparison to the fresh platelets (F=3.95, q=4.85-7.35, P0.01). Conclusion The second-messenger effectors could reduce the DMSO concentration. The 0.02 DMSO plus ThromboSol is superior to 0.06 DMSO in inhibiting the activation of platelets, and is stable within six months.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effect of cryopreservation with 0.02 dimethyl sulfoxide(DMSO) plus ThromboSol, a mixture of second-messenger effectors, on platelet membrane CD42b and CD62p, and to investigate the long-term (6 months) preservation effect of the platelet storage solution. Methods Platelet concentrates were treated with 0.02 DMSO, 0.06 DMSO and 0.02 DMSO plus ThromboSol, and then placed in liquid nitrogen. The samples were thawed and expression levels of CD42b and CD62p on platelet membrane were analyzed after one month, three months and six months, respectively. Results The platelet expression level of CD42b in the 0.02 DMSO-plus-ThromboSol group was not significantly different from those in the 0.06 DMSO group (F=3.13-5.01,q=1.12-1.76, P0.05), and the levels of both groups were higher than those in the 0.02 DMSO group (q=3.17-4.06, P0.05) one, three and six months later. The CD42b levels of the three groups were lower than those of the fresh platelets (q=3.09-4.15, P0.05). The platelets treated with 0.02 DMSO plus ThromboSol showed statistically lower CD62p expression than those frozen with 0.06 DMSO and 0.02 DMSO(F=5.75-9.77,q=3.20-4.34,P0.05). There were no obvious differences in CD62p expression between platelets treated with 0.06 DMSO and 0.02 DMSO (q=1.55-2.02, P0.05). But the three groups of frozen platelets showed significant increase of surface expression of CD62p in comparison to the fresh platelets (F=3.95, q=4.85-7.35, P0.01). Conclusion The second-messenger effectors could reduce the DMSO concentration. The 0.02 DMSO plus ThromboSol is superior to 0.06 DMSO in inhibiting the activation of platelets, and is stable within six months.

Key concepts: Dimethyl sulfoxide, Platelet, Cryopreservation, Andrology, Sulfoxide, Medicine, Chemistry, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
EFFECTS OF DIMETHYL SULFOXIDE AND SECOND-MESSENGER EFFECTOR ON CRYOPRESERVED PLATELET MEMBRANE EXPRESSIONS CD42b AND CD62p — Research Paper | ScholarLens